NFKB1 and Barrett esophagus: Although rarely activated in reflux esophagitis, NF-κB activation is increased in BE and EAC, which suggests that it may be a marker of metaplasia–dysplasia–adenocarcinoma progression in addition to its role as an inflammatory marker.